¼¼°èÀÇ ¼ÒÈ­°ü º´¿ø±Õ °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Gastrointestinal Pathogen Testing Global Market Report 2025
»óǰÄÚµå : 1704434
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,272,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,065,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,859,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼ÒÈ­°ü º´¿ø±Õ °Ë»ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö ¿¬Æò±Õ 4.3%ÀÇ ¼ºÀå·ü·Î 50¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ Áß ¼ºÀåÀÇ ¹è°æ¿¡´Â ¼¼°è ¼ÒÈ­±â °¨¿°ÁõÀÇ À¯Çà, Á¶±â ¹ß°ß ¹× Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë, ÇöÀå °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½Äǰ ¾ÈÀü ±ÔÁ¦¿¡ ´ëÇÑ °ü½É Áõ°¡, Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·Â µîÀÌ ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ½Å¼Ó °Ë»ç¹ý, ºÐÀÚÁø´Ü ±â¼ú äÅà Ȯ´ë, ºñ ÀüÅëÀûÀÎ ÀÇ·á ȯ°æ¿¡¼­ ÇöÀå °Ë»ç È®´ë, °Ë»ç ÇÁ·Î¼¼½º °£¼ÒÈ­¸¦ À§ÇÑ ÀÚµ¿È­ ¹× ·Îº¿ °øÇÐÀÇ ¹ßÀü, º´¿øÃ¼ °ËÃâÀ» °­È­Çϱâ À§ÇÑ »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÃâÇö, ÀΰøÁö´É ¹× ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù. ¾Ë°í¸®ÁòÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

½ÄÁßµ¶ Áõ°¡·Î ÀÎÇØ ¼ÒÈ­°ü º´¿ø±Õ °Ë»ç ½ÃÀåÀº ´çºÐ°£ È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù. ½ÄÁßµ¶Àº ¸®½ºÅ׸®¾ÆÁõ, ¹ÙÀÌ·¯½º¼º À§Àå¿°, ÀåÆ¼Çª½º, ¼±¸ðÃæÁõ°ú °°Àº Áúº´À» Æ÷ÇÔÇÏ¿© À¯ÇØÇÑ ¹Ì»ý¹°, µ¶¼Ò ¶Ç´Â È­Çй°Áú·Î ¿À¿°µÈ À½½ÄÀ̳ª À½·áÀÇ ¼·Ãë·Î ÀÎÇÑ Áúº´À» Æ÷ÇÔÇÕ´Ï´Ù. ½ÄÁßµ¶ÀÇ ±ÞÁõÀº ½Äǰ »ý»ê, À¯Åë, ¼Òºñ °üÇàÀÇ º¯È­, ºÒÃæºÐÇÑ ½Äǰ ¾ÈÀü ÇÁ·ÎÅäÄÝ, ±âÈÄ º¯È­°¡ ½Äǰ »ý»ê¿¡ ¹ÌÄ¡´Â ¿µÇâ µî ´Ù¾çÇÑ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. À§Àå °Ë»ç´Â ½ÄÁßµ¶À» À¯¹ßÇϴ ƯÁ¤ º´¿øÃ¼¸¦ ½Äº°Çϰí, ÀÇ·áÁøÀÌ À§Àå Áõ»óÀ» Áø´ÜÇϰí, ÀûÀýÇÑ Ä¡·á ¹æ¹ýÀ» °áÁ¤Çϰí, ¹ß»ýÀ» ¸ð´ÏÅ͸µÇϰí, ½ÄÁßµ¶ È®»êÀ» ¿ÏÈ­Çϱâ À§ÇÑ ¿¹¹æ Á¶Ä¡¸¦ ½ÃÇàÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 2¿ù ¿µ±¹ º¸°Ç¾ÈÀüû(UK Health Security Agency)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é À×±Û·£µå¿Í ¿þÀÏÁî¿¡¼­ ¸®½ºÅ׸®¾ÆÁõ »ç·Ê°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, 2021³â 160°Ç¿¡¼­ 2022³â 167°ÇÀÌ º¸°íµÈ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¼ÒÈ­°ü º´¿ø±Õ °Ë»çÀÇ Á߿伺ÀÌ ³ô¾ÆÁö°í ÀÖÀ½À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¼ÒÈ­°ü º´¿ø±Õ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¼ÒÈ­°ü º´¿ø±Õ °ËÃâÀÇ Á¤È®¼º, ¼Óµµ, Æ÷°ý¼ºÀ» ³ôÀ̱â À§ÇØ ¸ÞŸÀ¯Àüü Áø´Ü °Ë»ç¿Í °°Àº ÃÖ÷´Ü ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¸ÞŸÀ¯Àüü Áø´Ü°Ë»ç´Â ´ëº¯À̳ª Ç÷¾× µîÀÇ »ùÇÿ¡ Á¸ÀçÇÏ´Â ¹Ì»ý¹°ÀÇ À¯Àü¹°ÁúÀ» ºÐ¼®Çϱâ À§ÇØ È°¿ëµÇ´Â ÷´Ü ±â¼úÀÔ´Ï´Ù. ¿¹¸¦ µé¾î È£ÁÖ¿¡ º»»ç¸¦ µÐ »ý¸í°øÇÐ ±â¾÷ Microba Life Sciences´Â 2024³â 4¿ù, ±¤¹üÀ§ÇÑ ¼ÒÈ­°ü º´¿ø±ÕÀ» Àü·Ê ¾ø´Â Á¤È®µµ·Î ½Äº°Çϱâ À§ÇØ °³¹ßµÈ ¸ÞŸÀ¯Àüü Áø´Ü Å×½ºÆ®ÀÎ MetaPanelÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¸ÞŸÆÐ³ÎÀº ÇÑ ¹øÀÇ °Ë»ç·Î 175°³ÀÇ º´¿øÃ¼ Ÿ°ÙÀ» Æ÷°ýÇϸç, ÀϹÝÀûÀÎ °¨¿°¼º ÁúȯºÎÅÍ ±î´Ù·Î¿î °¨¿°¼º Áúȯ±îÁö Áø´ÜÇÒ ¼ö ÀÖ´Â Á¾ÇÕÀûÀÎ ÅøÀ» ÀÇ·áÁø¿¡°Ô Á¦°øÇÕ´Ï´Ù. ¸ÞŸÆÐ³ÎÀº Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ±â¼úÀ» Ȱ¿ëÇÏ¿© ´ëº¯ »ùÇÃÀÇ ´Ù¾çÇÑ À¯Àü¹°ÁúÀ» ºÐ¼®ÇÏ¿© ±âÁ¸ ¼ÒÈ­±â ÆÐ³Î¿¡¼­ ÀÏ»óÀûÀ¸·Î Æò°¡µÇÁö ¾Ê¾Ò´ø ´Ù¾çÇÑ ÀáÀçÀû º´¿ø±ÕÀ» °ËÃâÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Gastrointestinal pathogen testing refers to the diagnostic process aimed at identifying infections and diseases resulting from various pathogens affecting the digestive tract, which includes the stomach and intestines. This involves analyzing specimens such as stool or blood to identify the specific pathogens responsible for gastrointestinal symptoms, enabling accurate diagnosis and treatment of gastrointestinal disorders.

The primary types of pathogens targeted in gastrointestinal pathogen testing include bacteria, viruses, and parasites, all of which can cause illness in the digestive system. Various testing methods are employed, including molecular tests, culture techniques, biochemical assays, and others, with different panel types available, such as syndromic full multiplex panels and others. These testing services cater to a range of end-users, including hospitals, diagnostic laboratories, point-of-care facilities, and others.

The gastrointestinal pathogen testing market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal pathogen testing market statistics, including gastrointestinal pathogen testing industry global market size, regional shares, competitors with a gastrointestinal pathogen testing market share, detailed gastrointestinal pathogen testing market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal pathogen testing industry. This gastrointestinal pathogen testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal pathogen testing market size has grown steadily in recent years. It will grow from $4.05 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to the increased prevalence of gastrointestinal infections, growth in awareness about foodborne illnesses, globalization leading to higher travel-related infections, regulatory initiatives for food safety, rise in healthcare expenditure, and heightened demand for rapid and accurate diagnostic solutions.

The gastrointestinal pathogen testing market size is expected to see steady growth in the next few years. It will grow to $5.01 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal infections globally, growing awareness about the importance of early detection and treatment, expanding healthcare infrastructure in emerging economies, rising demand for point-of-care testing solutions, heightened focus on food safety regulations, and continuous research and development efforts. Major trends in the forecast period include rapid testing methods, growing adoption of molecular diagnostic techniques, expansion of point-of-care testing in non-traditional healthcare settings, advancements in automation and robotics for streamlined testing processes, the emergence of novel biomarkers for enhanced pathogen detection, and integration of artificial intelligence and machine learning algorithms.

The increasing occurrences of foodborne illnesses are poised to drive the expansion of the gastrointestinal pathogen testing market in the foreseeable future. Foodborne diseases encompass illnesses resulting from the consumption of food or beverages contaminated with harmful microorganisms, toxins, or chemical substances, including ailments such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The upsurge in foodborne incidents can be attributed to various factors such as shifts in food production, distribution, and consumption practices, inadequate food safety protocols, and the impacts of climate change on food production. Gastrointestinal testing plays a crucial role in identifying the specific pathogens responsible for foodborne illnesses, aiding healthcare providers in diagnosing gastrointestinal symptoms, determining suitable treatment approaches, monitoring outbreaks, and implementing preventive measures to mitigate the spread of foodborne diseases. For instance, data from the UK Health Security Agency in February 2024 revealed an increase in listeriosis cases in England and Wales, with 167 reported cases in 2022 compared to 160 cases in 2021, underscoring the growing significance of gastrointestinal pathogen testing.

Key players in the gastrointestinal pathogen testing market are directing their efforts towards developing cutting-edge solutions, such as metagenomic diagnostic tests, to enhance the precision, speed, and comprehensiveness of gastrointestinal pathogen detection. Metagenomic diagnostic tests represent advanced technologies utilized for analyzing the genetic material of microorganisms present in samples such as stool or blood. For example, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel in April 2024-a metagenomic diagnostic test engineered to identify a broad spectrum of gastrointestinal pathogens with unprecedented accuracy. MetaPanel encompasses 175 pathogen targets within a single test, offering healthcare practitioners a comprehensive tool for diagnosing both common and challenging infections. Leveraging next-generation sequencing (NGS) technology, MetaPanel analyzes a diverse range of genetic material in stool samples, enabling the detection of various potential pathogens, including those not routinely assessed in traditional gastrointestinal panels.

In August 2022, SSI Diagnostica Group (SSID), a Denmark-based in-vitro diagnostics company, completed the acquisition of TechLab for an undisclosed sum. This acquisition is envisioned to broaden SSID's portfolio of infectious disease products and facilitate accelerated growth in the US market. The strategic move brings valuable commercial and manufacturing expertise, particularly in the pivotal US market. TechLab, based in the US, specializes in delivering rapid diagnostic tests for infectious diseases associated with the gastrointestinal and enteric systems.

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastrointestinal pathogen testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal pathogen testing market consists of revenues earned by entities by providing services, such as molecular testing, culture and sensitivity testing, and rapid diagnostics tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal pathogen testing market also includes sales of testing kits, laboratory equipment, and PCR (Polymerase Chain Reaction) machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Pathogen Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal pathogen testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for gastrointestinal pathogen testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal pathogen testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Gastrointestinal Pathogen Testing Market Characteristics

3. Gastrointestinal Pathogen Testing Market Trends And Strategies

4. Gastrointestinal Pathogen Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gastrointestinal Pathogen Testing Growth Analysis And Strategic Analysis Framework

6. Gastrointestinal Pathogen Testing Market Segmentation

7. Gastrointestinal Pathogen Testing Market Regional And Country Analysis

8. Asia-Pacific Gastrointestinal Pathogen Testing Market

9. China Gastrointestinal Pathogen Testing Market

10. India Gastrointestinal Pathogen Testing Market

11. Japan Gastrointestinal Pathogen Testing Market

12. Australia Gastrointestinal Pathogen Testing Market

13. Indonesia Gastrointestinal Pathogen Testing Market

14. South Korea Gastrointestinal Pathogen Testing Market

15. Western Europe Gastrointestinal Pathogen Testing Market

16. UK Gastrointestinal Pathogen Testing Market

17. Germany Gastrointestinal Pathogen Testing Market

18. France Gastrointestinal Pathogen Testing Market

19. Italy Gastrointestinal Pathogen Testing Market

20. Spain Gastrointestinal Pathogen Testing Market

21. Eastern Europe Gastrointestinal Pathogen Testing Market

22. Russia Gastrointestinal Pathogen Testing Market

23. North America Gastrointestinal Pathogen Testing Market

24. USA Gastrointestinal Pathogen Testing Market

25. Canada Gastrointestinal Pathogen Testing Market

26. South America Gastrointestinal Pathogen Testing Market

27. Brazil Gastrointestinal Pathogen Testing Market

28. Middle East Gastrointestinal Pathogen Testing Market

29. Africa Gastrointestinal Pathogen Testing Market

30. Gastrointestinal Pathogen Testing Market Competitive Landscape And Company Profiles

31. Gastrointestinal Pathogen Testing Market Other Major And Innovative Companies

32. Global Gastrointestinal Pathogen Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Pathogen Testing Market

34. Recent Developments In The Gastrointestinal Pathogen Testing Market

35. Gastrointestinal Pathogen Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â